{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:57:15Z","timestamp":1781081835115,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.brainres.2026.150385","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:38:46Z","timestamp":1778711926000},"page":"150385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combination of alantolactone and temozolomide targets stemness and lipid metabolism in glioblastoma through YAP1-Hippo signaling"],"prefix":"10.1016","volume":"1887","author":[{"given":"Tong","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2026.150385_b0005","article-title":"Costunolide and parthenolide: Novel blood-brain barrier permeable sesquiterpene lactones to improve barrier tightness","volume":"167","author":"\u00c1vila-G\u00e1lvez","year":"2023","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.brainres.2026.150385_b0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4103\/1735-5362.301340","article-title":"Alantolactone inhibits stem-like cell phenotype, chemoresistance and metastasis in PC3 cells through STAT3 signaling pathway","volume":"15","author":"Babaei","year":"2020","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.brainres.2026.150385_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111231","article-title":"A comprehensive review of anticancer mechanisms of action of Alantolactone","volume":"136","author":"Babaei","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.brainres.2026.150385_b0020","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/neuonc\/noab244","article-title":"Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models","volume":"24","author":"Barrette","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.brainres.2026.150385_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.781033","article-title":"Alantolactone: a natural plant extract as a potential therapeutic agent for cancer","volume":"12","author":"Cai","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2026.150385_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044217","article-title":"The \u201cSuperoncogene\u201d Myc at the crossroad between metabolism and gene expression in glioblastoma multiforme","volume":"24","author":"Cencioni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.brainres.2026.150385_b0035","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41401-022-00984-6","article-title":"Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide","volume":"44","author":"Choo","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.brainres.2026.150385_b0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/CS20201474","article-title":"The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer","volume":"136","author":"Cunningham","year":"2022","journal-title":"Clin. Sci. (Lond.)"},{"issue":"5","key":"10.1016\/j.brainres.2026.150385_b0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000531319","article-title":"Glioblastoma multiforme: the latest diagnostics and treatment techniques","volume":"108","author":"Czarnywojtek","year":"2023","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2026.150385_b0050","article-title":"Targeted c-Myc inhibition and systemic temozolomide therapy extend survival in glioblastoma xenografts","volume":"10","author":"Dhungel","year":"2023","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.brainres.2026.150385_b0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","article-title":"Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance","volume":"83","author":"Fatma","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.brainres.2026.150385_b0060","article-title":"Natural product alantolactone targeting AKR1C1 suppresses cell proliferation and metastasis in non-small-cell lung cancer","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2026.150385_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-025-01375-7","article-title":"Excitatory amino acid transporters support mast cell degranulation via \u03b1-KG-mediated methylation of Spp1","author":"Gan","year":"2026","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.brainres.2026.150385_b0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fonc.2019.00118","article-title":"Glioblastoma stem-like cells, metabolic strategy to kill a challenging target","volume":"9","author":"Garnier","year":"2019","journal-title":"Front. Oncol."},{"issue":"11\u201312","key":"10.1016\/j.brainres.2026.150385_b0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1101\/gad.324301.119","article-title":"Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer","volume":"33","author":"Gimple","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.brainres.2026.150385_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2018.08.003","article-title":"Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB","volume":"356","author":"He","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.brainres.2026.150385_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154528","article-title":"Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway","volume":"108","author":"Hu","year":"2023","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.brainres.2026.150385_b0090","first-page":"441","article-title":"Isolation and characterization of cancer stem cells derived from human glioblastoma","volume":"11","author":"Ishii","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"7","key":"10.1016\/j.brainres.2026.150385_b0095","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/0008-5472.CAN-22-2586","article-title":"Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer","volume":"83","author":"Jagadeeshan","year":"2023","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.brainres.2026.150385_b0100","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/curroncol31070296","article-title":"Temozolomide (TMZ) in the treatment of glioblastoma multiforme-a literature review and clinical outcomes","volume":"31","author":"Jezierzanski","year":"2024","journal-title":"Curr. Oncol."},{"issue":"8","key":"10.1016\/j.brainres.2026.150385_b0105","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/1535-7163.MCT-24-0594","article-title":"Moxidectin unravels the role of the hippo-YAP pathway in maintaining immunity of glioblastoma multiforme","volume":"24","author":"Kaushik","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.brainres.2026.150385_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/719858","article-title":"Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction","volume":"2013","author":"Khan","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"7","key":"10.1016\/j.brainres.2026.150385_b0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tcb.2024.04.009","article-title":"Biomolecular condensates: hubs of Hippo-YAP\/TAZ signaling in cancer","volume":"34","author":"Kiang","year":"2024","journal-title":"Trends Cell Biol."},{"issue":"4","key":"10.1016\/j.brainres.2026.150385_b0120","article-title":"Multiple therapeutic approaches of glioblastoma multiforme: from terminal to therapy","volume":"1878","author":"Kumari","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.brainres.2026.150385_b0125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00018-022-04420-0","article-title":"CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling","volume":"79","author":"Liang","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.brainres.2026.150385_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13659-024-00462-y","article-title":"5\u03b1-Epoxyalantolactone from Inula macrophylla attenuates cognitive deficits in scopolamine-induced Alzheimer's disease mice model","volume":"14","author":"Ma","year":"2024","journal-title":"Nat. Prod. Bioprospect."},{"issue":"4","key":"10.1016\/j.brainres.2026.150385_b0135","first-page":"790","article-title":"Cell competition in mouse NIH3T3 embryonic fibroblasts is controlled by the activity of Tead family proteins and Myc","volume":"128","author":"Mamada","year":"2015","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.brainres.2026.150385_b0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/biomedicines13010133","article-title":"Sesquiterpene lactones as promising anti-glioblastoma drug candidates exerting complex effects on glioblastoma cell viability and proneural-mesenchymal transition","volume":"13","author":"Markov","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.brainres.2026.150385_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118143","article-title":"Inhibitory effects of kukoamine B on adipogenesis and lipid accumulation in vitro and obesity in vivo","volume":"187","author":"Oh","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.brainres.2026.150385_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/diseases11020086","article-title":"Mechanical properties of glioblastoma: perspectives for YAP\/TAZ signaling pathway and beyond","volume":"11","author":"Pontes","year":"2023","journal-title":"Diseases"},{"issue":"1","key":"10.1016\/j.brainres.2026.150385_b0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.brainres.2026.150385_b0160","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1007\/s11010-021-04247-6","article-title":"Alantolactone exhibits antiproliferative and apoptosis-promoting properties in colon cancer model via activation of the MAPK-JNK\/c-Jun signaling pathway","volume":"476","author":"Ren","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"24","key":"10.1016\/j.brainres.2026.150385_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70304","article-title":"A role for the hippo\/YAP1 pathway in the regulation of in vitro vasculogenic mimicry in glioblastoma cells","volume":"28","author":"Roy","year":"2024","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.brainres.2026.150385_b0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11060-021-03699-6","article-title":"Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma","volume":"152","author":"Saunders","year":"2021","journal-title":"J. Neurooncol"},{"issue":"3","key":"10.1016\/j.brainres.2026.150385_b0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/17512433.2020.1738218","article-title":"Cancer prevention and treatment using combination therapy with natural compounds","volume":"13","author":"Sauter","year":"2020","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2026.150385_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020982","article-title":"Regulation of the receptor tyrosine kinase AXL in response to therapy and its role in therapy resistance in glioblastoma","volume":"23","author":"Scherschinski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2026.150385_b0185","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2321770","article-title":"RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT\/GSK3-beta pathway","volume":"25","author":"Sun","year":"2024","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.brainres.2026.150385_b0190","article-title":"Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.brainres.2026.150385_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234986","article-title":"Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue","volume":"15","author":"Wallenborn","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.brainres.2026.150385_b0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13046-017-0563-8","article-title":"Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKbeta kinase activity and interrupting NF-kappaB\/COX-2-mediated signaling cascades","volume":"36","author":"Wang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.brainres.2026.150385_b0205","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4901","article-title":"Alantolactone suppresses the metastatic phenotype and induces the apoptosis of glioblastoma cells by targeting LIMK kinase activity and activating the cofilin\/G\u2011actin signaling cascade","volume":"47","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.brainres.2026.150385_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.241","article-title":"Interaction between intestinal mycobiota and microbiota shapes lung inflammation","volume":"3","author":"Wang","year":"2024","journal-title":"iMeta"},{"key":"10.1016\/j.brainres.2026.150385_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109845","article-title":"Oridonin suppresses the growth of glioblastoma cells via inhibiting Hippo\/YAP axis","volume":"751","author":"Wang","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"40","key":"10.1016\/j.brainres.2026.150385_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg1850","article-title":"YAP drives fate conversion and chemoresistance of small cell lung cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.brainres.2026.150385_b0225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13046-023-02659-4","article-title":"FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling","volume":"42","author":"Yang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.brainres.2026.150385_b0230","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1097\/TP.0000000000005036","article-title":"Gas6\/AXL alleviates hepatic ischemia\/reperfusion injury by inhibiting ferroptosis via the PI3K\/AKT pathway","volume":"108","author":"Zhan","year":"2024","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.brainres.2026.150385_b0235","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1248\/bpb.b23-00804","article-title":"Alantolactone induced apoptosis and DNA damage of cervical cancer through ATM\/CHK2 signaling pathway","volume":"47","author":"Zhang","year":"2024","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.brainres.2026.150385_b0240","first-page":"4795","article-title":"Alantolactone induces gastric cancer BGC-823 cell apoptosis by regulating reactive oxygen species generation and the AKT signaling pathway","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326002453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326002453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:00:01Z","timestamp":1781078401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899326002453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0006899326002453"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150385","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of alantolactone and temozolomide targets stemness and lipid metabolism in glioblastoma through YAP1-Hippo signaling","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150385"}}